Abstract
BackgroundTIL therapy is a promising approach to the treatment of advanced solid tumors, but efficacy is limited by T-cell exhaustion and terminal differentiation. In addition, recent studies highlight the detrimental...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
